Gilead Sciences Option Alert: Fri $125 Calls at the Bid: 7380 vs 10582 OI

Gilead Sciences Option Alert: Fri $125 Calls at the Bid: 7380 @ $1.7 vs 10582 OI; Ref=$126.435

Gilead Sciences Option Alert: Jan 16 $135 Calls at the Bid: 3299 vs 1124 OI

Gilead Sciences Option Alert: Jan 16 $135 Calls at the Bid: 3299 @ $2.32 vs 1124 OI; Ref=$125.5699

Gilead Sciences (NASDAQ:GILD) Azioni, Quote.MetaTitle.unusual-options

Gilead Sciences

Panoramica

Notizie

Utili

Opzioni

Guidance

Dividendi

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Commerci governativi

Rapporto azionario

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
10:33 AMNov 21, 2025	CALL	$125.00	Nov 21, 2025	-4	160	7380	2	10582	TRADE	NEUTRAL
11:11 AMNov 17, 2025	CALL	$135.00	Jan 16, 2026	52	3984	3299	354	1124	TRADE	BEARISH

Comments

Gilead Sciences Opzioni Inusuali

Attività insolita sulle opzioni per Gilead Sciences Inc (NASDAQ:GILD)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO